Terms of Use
Effective Date: June 22, 2026
These Terms of Use apply to the website operated by Trevarx Biomedical, Inc. (“Trevarx,” “we,” “our,” or “us”), including any webpages, content, contact forms, materials, and other online features that link to or display these Terms of Use (collectively, the “Site”).
By accessing or using the Site, you agree to these Terms of Use. If you do not agree, please do not use the Site.
1. Intended Audience
This Site is intended for general corporate, scientific, business-development, investor-relations, and informational purposes. It is intended primarily for institutional investors, scientific and medical professionals, potential collaborators, business partners, and other corporate stakeholders.
This Site is not intended as a patient-directed treatment resource, medical advice platform, clinical trial recruitment platform, emergency medical resource, or substitute for consultation with a qualified healthcare professional.
2. No Medical Advice
The content on this Site is provided for general informational purposes only. It is not intended to provide, and should not be relied upon as, medical advice, diagnosis, treatment, disease-management guidance, or a recommendation regarding any disease, condition, product, procedure, therapy, or course of treatment.
Patients and caregivers should consult qualified healthcare professionals regarding medical questions. If you believe you may be experiencing a medical emergency, call emergency services immediately.
3. Investigational Products; No Product Promotion
Trevarx is developing investigational product candidates. Trevarx’s product candidates, including AlphaPARP and PARPTrace, are investigational and have not been approved by the U.S. Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.
Nothing on this Site is intended to promote any investigational product, recommend any investigational therapy, or suggest that any investigational product is safe or effective for any disease, condition, or indication.
Information regarding Trevarx’s platform, product candidates, potential mechanisms of action, development plans, regulatory pathways, potential indications, or future milestones reflects current scientific rationale, preclinical research, development-stage planning, and business judgment, and remains subject to further validation.
Preclinical results may not be predictive of results in humans. References to potential clinical, regulatory, or commercial opportunities do not imply regulatory approval, clinical benefit, safety, efficacy, commercial availability, or successful development.
4. Scientific and Technical Information
Scientific, technical, and pipeline information presented on this Site may include summaries, hypotheses, illustrations, design rationales, preclinical observations, development plans, or other information that is subject to change. Trevarx does not undertake any obligation to update scientific, technical, regulatory, or pipeline information except as required by applicable law.
The Site may simplify complex scientific concepts for general audience understanding. Any such simplification should not be interpreted as a complete scientific, regulatory, clinical, manufacturing, intellectual-property, or investment analysis.
Descriptions of mechanism of action, intracellular and DNA-site delivery, cytotoxicity, biodistribution, dosimetry, or other scientific or technical effects reflect preclinical or translational research and do not represent established safety or efficacy in humans.
5. No Offer of Securities or Investment Advice
Nothing on this Site constitutes or should be construed as an offer to sell, or a solicitation of an offer to buy, any securities or other financial instruments. Any securities offering, if made, will be made only through formal offering materials and in compliance with applicable securities laws.
Nothing on this Site constitutes investment, financial, legal, tax, medical, regulatory, or other professional advice. Users should consult their own advisors before making any business, investment, legal, medical, or other decisions.
6. Forward-Looking Statements
This Site may contain forward-looking statements regarding Trevarx’s business, product candidates, platform, research and development activities, regulatory plans, financing plans, potential indications, potential collaborations, anticipated milestones, or future opportunities.
Forward-looking statements are based on current expectations and assumptions and are subject to scientific, clinical, regulatory, manufacturing, financing, intellectual-property, market, competitive, operational, and other risks and uncertainties. Actual results may differ materially from those expressed or implied.
Trevarx undertakes no obligation to update any forward-looking statements except as required by applicable law.
7. Intellectual Property
The Site and its contents, including text, graphics, images, logos, designs, icons, names, trademarks, service marks, trade dress, videos, software, data, scientific illustrations, and other materials, are owned by Trevarx or its licensors and are protected by applicable intellectual-property and other laws.
You may view and use the Site for lawful informational purposes only. No content from the Site may be copied, reproduced, modified, distributed, displayed, transmitted, published, licensed, reverse engineered, scraped, harvested, sold, or used to create derivative works without Trevarx’s prior written permission, except as permitted by applicable law.
No license or right under any patent, trademark, copyright, trade secret, or other intellectual-property right is granted by your access to or use of the Site.
8. Permitted Use of the Site
You agree to use the Site only for lawful purposes and in accordance with these Terms of Use. You may not:
Trevarx may restrict, suspend, or terminate access to the Site at any time and for any reason.
9. Third-Party Links and References
The Site may contain links or references to third-party websites, publications, platforms, service providers, articles, studies, or other resources. These links and references are provided for convenience only. Trevarx does not control and is not responsible for third-party content, privacy practices, products, services, claims, or policies.
The inclusion of a third-party link or reference does not imply endorsement, approval, sponsorship, or affiliation.
10. No Confidential or Proprietary Submissions
Please do not submit confidential business information, trade secrets, proprietary ideas, unpublished patentable concepts, personal health information, patient information, medical information, or other sensitive information through the Site or any contact form.
Unless Trevarx has entered into a separate written confidentiality agreement with you, information submitted through the Site will be treated as non-confidential and non-proprietary. Trevarx will have no obligation to review, return, protect, or compensate you for any unsolicited submission. Trevarx does not wish to receive, and assumes no obligation with respect to, unsolicited ideas for products, technologies, clinical programs, business models, or other inventions submitted through the Site.
11. Disclaimer of Warranties
The Site and all content are provided on an “as is” and “as available” basis. Trevarx makes no warranties or representations of any kind, express or implied, regarding the Site or its content, including warranties of accuracy, completeness, timeliness, availability, reliability, fitness for a particular purpose, non-infringement, merchantability, or freedom from errors, viruses, or other harmful components.
Trevarx does not warrant that the Site will be uninterrupted, secure, current, complete, or error-free.
12. Limitation of Liability
To the fullest extent permitted by applicable law, Trevarx and its officers, directors, employees, consultants, advisors, agents, representatives, affiliates, licensors, and service providers will not be liable for any direct, indirect, incidental, consequential, special, exemplary, punitive, or other damages arising out of or relating to your access to, use of, or inability to use the Site or any content on the Site.
This limitation applies regardless of the legal theory asserted and even if Trevarx has been advised of the possibility of such damages.
13. Indemnification
You agree to indemnify, defend, and hold harmless Trevarx and its officers, directors, employees, consultants, advisors, agents, representatives, affiliates, licensors, and service providers from and against any claims, liabilities, damages, losses, costs, and expenses, including reasonable attorneys’ fees, arising out of or relating to your use of the Site, your violation of these Terms of Use, your violation of applicable law, or your submission of information through the Site.
14. Changes to the Site and Terms
Trevarx may update, modify, suspend, or discontinue the Site or any content at any time without notice. Trevarx may also update these Terms of Use from time to time.
The updated version will be posted on the Site with a revised effective date. Your continued use of the Site after an updated version is posted means you accept the updated Terms of Use.
15. Governing Law
These Terms of Use are governed by the laws of the State of Delaware, without regard to conflict-of-law principles. Any dispute arising out of or relating to the Site or these Terms of Use will be brought in the state or federal courts located in Delaware, unless otherwise required by applicable law.
16. Contact Information
For questions about these Terms of Use or the Site, please contact:
Trevarx Biomedical, Inc.
Email: info@trevarx.com
Mailing Address: 2929 Arch St., Floor 3, Philadelphia, PA 19104
Website Contact Page: www.trevarx.com
